SENEXON-S (NCS HealthCare of KY, Inc dba Vangard Labs)


Welcome to the PulseAid listing for the SENEXON-S drug offered from NCS HealthCare of KY, Inc dba Vangard Labs. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: NCS HealthCare of KY, Inc dba Vangard Labs
NON-PROPRIETARY NAME: docusate sodium-sennosides tablet
SUBSTANCE NAME: SENNOSIDES A AND B; DOCUSATE SODIUM
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: TABLET, COATED
MARKETING CATEGORY NAME: OTC MONOGRAPH NOT FINAL
START MARKETING DATE: 2006-02-09
END MARKETING DATE: 0000-00-00


SENEXON-S HUMAN OTC DRUG Details:

Item DescriptionSENEXON-S from NCS HealthCare of KY, Inc dba Vangard Labs
LABELER NAME: NCS HealthCare of KY, Inc dba Vangard Labs
DEA SCHEDULE:
ACTIVE STRENGTH: 8.6; 50(mg/1; mg/1)
START MARKETING DATE: 2006-02-09
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0615-7773_7769018d-0184-4e86-b09b-e7ae38addfe5
PRODUCT NDC: 0615-7773
APPLICATION NUMBER: part334

Other SENNOSIDES A AND B; DOCUSATE SODIUM Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
NCS HealthCare of KY, Inc dba Vangard LabsSENEXON-S